文献速递腹部外周血管MRCT

双动脉期钆塞酸增强MRA与CTA对潜在肝供者肝血管显示的比较

Comparison of dual arterial phase gadoxetic acid enhanced MRA with CTA for depiction of hepatic vasculature in potential liver donor candidates.
PubMed 文献 · Eur J Radiol · 2025-08-08

回顾性纳入81例连续活体肝供者候选者,以CTA为参考标准,评估双动脉期钆塞酸增强CAIPIRINHA MRI显示肝血管的能力。MRA对肝动脉、IV段动脉起源、门静脉和肝静脉变异的准确率分别为0.78、0.5、0.9和0.6;肝动脉图像质量主观评分MRA显著低于CTA(p<0.001)。作者认为MRA可作为替代方法,但因肝动脉变异(尤其IV段动脉起源)评估受限,目前不能完全替代CTA作为首选影像模态。

要点

  • MRA对门静脉变异显示准确率0.9,对肝静脉变异0.6,对肝动脉变异0.78。
  • MRA对IV段动脉起源判断准确率仅0.5,是最常见错误来源。
  • MRA肝动脉图像质量主观评分显著低于CTA(p<0.001)。

核心结论

  • 双动脉期钆塞酸增强CAIPIRINHA MRI可作为潜在肝供者肝血管评估的替代方法,但因肝动脉变异(尤其IV段动脉起源)评估受限,目前不能完全替代CTA作为首选影像模态。

研究设计与样本

  • 伦理委员会批准的回顾性研究,纳入81例连续活体肝供者候选者(男31例、女50例;平均年龄37岁,范围22-58岁),均有术前CTA和MRA。

关键影像表现/征象

  • MRA整体诊断质量优秀,但肝动脉显示的主观图像质量显著低于CTA(p<0.001)。
  • MRA对肝动脉5型和11型变异显示良好,但IV段动脉起源误判是最常见错误。
  • MRA和CTA对门静脉解剖显示良好,但2型和3型除外。
  • MRA对肝静脉2型和5型变异显示不一致。

诊断标准与关键数值

  • 以共识CTA读片为参考标准,MRA显示肝动脉变异的准确率为0.78。
  • MRA显示IV段动脉起源变异的准确率为0.5。
  • MRA显示门静脉变异的准确率为0.9。
  • MRA显示肝静脉变异的准确率为0.6。

临床应用与阅片要点

  • 潜在肝供者术前评估可参考双动脉期钆塞酸增强MRA,但肝动脉变异尤其IV段动脉起源需结合CTA确认。
  • MRA对门静脉变异显示准确率较高(0.9),对肝静脉2型和5型变异需注意显示不一致。
  • MRA肝动脉图像质量主观评分低于CTA(p<0.001),阅片时需关注肝动脉细节显示。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine the ability of dual-arterial phase gadoxetic acid-enhanced CAIPIRINHA MRI in preoperative assessment of hepatic vasculature in potential living liver donors with CTA as the reference standard.

METHODS: In this ethics board approved retrospective study, 81 consecutive living liver donor candidates (31 men, 50 women; mean age 37 years, range 22-58 years) with preoperative CTA and MRA were included. Study cohort subjects had undergone liver CT and MRI as per the standard departmental liver donor protocols. MRI protocol included dual arterial phase CAIPIRINHA acquisitions following gadoxetic acid administration. Two independent blinded radiologists reviewed MRA images for 1) image quality and confidence scores in identifying hepatic vasculature and 2) inter-modality agreement in characterizing hepatic vascular variants, with consensus CTA readings as the reference standard. Statistical analysis was performed to determine the accuracy of MRI for determination of variant hepatic vasculature in reference to CTA.

RESULTS: The MRI accuracy for depicting hepatic arterial, segment IV arterial origin, portal, and hepatic venous variants was 0.78, 0.5, 0.9, and 0.6, respectively, compared to CTA. While MR scans exhibited overall excellent diagnostic quality, subjective image quality for hepatic artery depiction in MRA was significantly lower than in CTA (p < 0.001). Most arterial variants were well identified on MRA, except for types 5 and 11. Incorrect determination of Segment IV artery origin was the most frequent error with MRA. Portal venous anatomy was well characterized by both MRA and CTA, except for types 2 and 3. MRI exhibited inconsistency in accurately characterizing type 2 and 5 hepatic venous variants.

CONCLUSION: CAIPIRINHA protocol-enabled dual-arterial multiphase gadoxetic acid-enhanced MRI presents an alternative approach for evaluating hepatic vascular anatomy in potential liver donors compared to CTA. However, due to its limitations in assessing anatomical variations of the hepatic arterial vasculature particularly the origin of segment IV artery, absolute replacement of CTA with MRA as the primary imaging modality is currently not justifiable.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Serrao EM, Odreda D, Basso-Dias A, et al. Comparison of dual arterial phase gadoxetic acid enhanced MRA with CTA for depiction of hepatic vasculature in potential liver donor candidates. Eur J Radiol. 2025. PMID: 40818218. doi:10.1016/j.ejrad.2025.112335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。